Market Cap | 19.25M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -26.17M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 13.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 32.00% |
Dividend | N/A | Price/Book | 0.86 | EPS next 5Y | - | 52W High Chg | -53.00% |
Recommedations | - | Quick Ratio | 1.39 | Shares Outstanding | 55.22M | 52W Low Chg | 217.00% |
Insider Own | 29.80% | ROA | -44.91% | Shares Float | 32.39M | Beta | 1.31 |
Inst Own | 25.52% | ROE | -216.99% | Shares Shorted/Prior | 155.07K/442.65K | Price | 0.42 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 178,893 | Target Price | - |
Oper. Margin | - | Earnings Date | May 10 | Volume | 16,114 | Change | -2.10% |
BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
HC Wainwright & Co. | Buy | Apr 22, 24 |
HC Wainwright & Co. | Buy | Apr 3, 24 |
HC Wainwright & Co. | Buy | Mar 7, 24 |
HC Wainwright & Co. | Buy | Nov 14, 23 |
HC Wainwright & Co. | Buy | Aug 9, 23 |
HC Wainwright & Co. | Buy | May 15, 23 |
Chardan Capital | Buy | Nov 10, 22 |
Chardan Capital | Buy | May 24, 22 |
Ladenburg Thalmann | Buy | May 12, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Oron Assaf | Chief Business Offic.. Chief Business Officer | May 22 | Buy | 0.2731 | 3,192 | 872 | 10,914 | 05/24/23 |
OrbiMed Israel BioFund GP Limi... | 10% Owner 10% Owner | Feb 27 | Buy | 0.245 | 348,000 | 85,260 | 3,161,489 | 03/17/23 |
Ugwumba Chidozie | Other Other | Oct 17 | Sell | 0.36 | 74,955 | 26,984 | 2,997,025 | 11/14/22 |
Ugwumba Chidozie | Other Other | Aug 10 | Sell | 0.62 | 288,619 | 178,944 | 3,349,227 | 11/14/22 |